NICE approve new arthritis drug24th October 2007
A new drug has been approved for the treatment of rheumatoid arthritis (RA).
The National Institute for Health and Clinical Excellence (NICE) has recommended that adalimumab should be offered to adults with rheumatoid arthritis that have already tried two disease-modifying anti-rheumatic drugs. Arthritis Care welcomed the new NICE guidelines and said that the drugs were â€ślife changing and in some cases life savingâ€? while NICE chief executive Andrew Dillon said that the approval of adalimumab, along with two other drugs, etanercept and infliximab, was good news for patients with RA.
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: NICE approve new arthritis drug
Author: Mark Nicholls
Article Id: 4551
Date Added: 24th Oct 2007